CryoPort Inc (OTCMKTS:CYRX) was upgraded by equities researchers at ValuEngine from a “sell” rating to a “hold” rating in a research note issued to investors on Friday, May 12th, StockTargetPrices.com reports. The brokerage presently has a $122.00 target price on the consumer goods maker’s stock.
Separately, Needham & Company LLC initiated coverage on shares of CryoPort in a research note on Monday, April 3rd. They set a “buy” rating and a $3.50 target price for the company.
Shares of CryoPort (OTCMKTS:CYRX) traded up 0.21% during midday trading on Friday, hitting $4.68. The company’s stock had a trading volume of 309,540 shares. The firm’s market cap is $112.20 million. CryoPort has a 52-week low of $1.50 and a 52-week high of $4.75. The stock’s 50 day moving average is $3.35 and its 200-day moving average is $3.12.
ILLEGAL ACTIVITY WARNING: This article was first published by Community Financial News and is the sole property of of Community Financial News. If you are viewing this article on another domain, it was stolen and reposted in violation of United States & international copyright and trademark law. The original version of this article can be read at https://www.com-unik.info/2017/06/17/valuengine-upgrades-cryoport-inc-cyrx-to-hold-updated-updated-updated.html.
CryoPort Company Profile
Cryoport, Inc (Cryoport) is a provider of cryogenic logistics solutions to the life sciences industry through its purpose-built packaging, information technology and specialized cold chain logistics expertise. The Company provides logistics solutions for biologic materials, such as immunotherapies, stem cells, chimeric antigen receptors (CAR)-T cells, and reproductive cells for clients.
To view ValuEngine’s full report, visit ValuEngine’s official website.
What are top analysts saying about CryoPort Inc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for CryoPort Inc and related companies.